MP:0000221 | decreased WBC count | "fewer than normal numbers of WBCs" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Aqp2tm1(cre)Blyg/Aqp2tm1(cre)Blyg Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0000223 | decreased monocyte count | "fewer than normal monocyte numbers" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Aqp2tm1(cre)Blyg/Aqp2tm1(cre)Blyg Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0001560 | abnormal circulating insulin level | "anomalous blood concentration of this polypeptide hormone, secreted by beta cells of the pancreas, that promotes glucose utilization, protein synthesis, and the formation and storage of neutral lipids" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Aqp2tm1(cre)Blyg/Aqp2tm1(cre)Blyg Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0002078 | abnormal glucose homeostasis | "anomaly in the state of equilibrium or processing in the body with respect to glucose in the fluids and tissues" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Aqp2tm1(cre)Blyg/Aqp2tm1(cre)Blyg Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0002891 | increased insulin sensitivity | "greater ability to clear glucose from the bloodstream when given insulin than normal; can result in hypoglycemia" [RGD:Rat Genome Database submission] |
Show
Allelic Composition: Aqp2tm1(cre)Blyg/Aqp2tm1(cre)Blyg Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0005016 | decreased lymphocyte number | "fewer than normal white blood cell numbers " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Aqp2tm1(cre)Blyg/Aqp2tm1(cre)Blyg Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0005292 | improved glucose tolerance | "better than the normal response to oral consumption or intravenous injection of specified amounts of glucose and indicative of insulin sensitivity; measured by determining whole blood or plasma sugar level in a fasting state before and after taking glucose at specified intervals" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Aqp2tm1(cre)Blyg/Aqp2tm1(cre)Blyg Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0005318 | decreased triglyceride level | "lower than normal concentration of triacylglycerols " [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Aqp2tm1(cre)Blyg/Aqp2tm1(cre)Blyg Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0005670 | abnormal white fat physiology | "functional aberration in the connective tissue consisting of fat-storing cells and arranged in lobular groups or along minor blood vessels" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Aqp2tm1(cre)Blyg/Aqp2tm1(cre)Blyg Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0006094 | adipocyte hypertrophy | "increase in the size of fat cells" [smb:Susan M Bello, Mouse Genome Informatics Curator, J:90802] |
Show
Allelic Composition: Aqp2tm1(cre)Blyg/Aqp2tm1(cre)Blyg Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|